Completed PHASE2 INTERVENTIONAL 2-arm NCT00672074

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients

Sponsor: Helsinn Therapeutics (U.S.), Inc

Conditions Ileus

Interventions Ipamorelin placebo

Updated 8 times since 2017 Last updated: Apr 12, 2017 Started: Apr 30, 2008 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00672074, this PHASE2 trial focuses on Ileus and remains completed. Sponsored by Helsinn Therapeutics (U.S.), Inc, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Helsinn Therapeutics (U.S.), Inc

Data source: Helsinn Therapeutics (U.S.), Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Aurora, United States , Chicago, United States , Cincinnati, United States , Cleveland, United States , Denver, United States , Hershey, United States , Indianapolis, United States , Los Angeles, United States , New Orleans, United States and 8 more locations